Active, Not Recruiting
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
NCT04380636
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- University of South Alabama, Mitchell Cancer Institute ( Site 0003) Mobile, Alabama, United States
- St. Bernards Medical Center ( Site 0089) Jonesboro, Arkansas, United States
- St Joseph Heritage Healthcare-Oncology ( Site 0088) Fullerton, California, United States
- Long Beach Memorial Medical Center ( Site 0006) Long Beach, California, United States